Futuretech II Acquisition Corp
Change company Symbol lookup
Select an option...
FTIIU Futuretech II Acquisition Corp
JBL Jabil Inc
AZO Autozone Inc
ALHC Alignment Healthcare Inc
PRGS Progress Software Corp
PMD Psychemedics Corp
RPHM Reneo Pharmaceuticals Inc
DFSU Dimensional US Sustainability Core 1 ETF
UNH UnitedHealth Group Inc

Company profile

FutureTech II Acquisition Corp. is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company intends to focus its search on companies in the technology industry. The Company has not commenced any operations nor generated any revenues.

Closing Price
Day's Change
0.05 (0.48%)
B/A Size
Day's High
Day's Low

10-day average volume:

Novavax initiates trial of COVID-flu combination vaccine candidate

8:14 am ET December 30, 2022 (MarketWatch)

Novavax Inc. (NVAX) said Friday that it has initiated a Phase 2 trial for its COVID-19-Influenza Combination (CIC) vaccine candidate, as well as for a stand-alone flu vaccine candidate. The biotechnology company said the trial will evaluate the safety and effectiveness of different formulations of the CIC and flu vaccine candidates in peopled aged 50 through 80. "We believe that like influenza, COVID-19 will also be seasonal moving forward, and that there is room in the market for new alternatives to provide better protection against the impact of influenza, particularly in older adults, and to explore the potential to combine this with protection from COVID," said Chief Executive Stanley Erck. The company said it expects initial results from the Phase 2 trial in mid-year 2023. The stock fell 1.9% in premarket trading Friday, after surging 9.7% over the past two days off a more-than 2 1/2-year low on Tuesday. Year to date, the stock has plummeted 93.2% through Thursday, while the iShares Biotechnology ETF (IBB) has declined 13.9% and the S&P 500 has lost 19.2%.

-Tomi Kilgore


(END) Dow Jones Newswires

December 30, 2022 08:14 ET (13:14 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.